Likewise, CD8+ TTM and CD8+ TEM proportions were the most abundant differentiation stages in ascites (TTM: 27.42 ± 6.06% of CD8+ T cells, TEM: 21.11 ± 6.46% of CD8+ T cells) and tumor samples (TTM: 28.62 ± 5.97% of CD8+ T cells, TEM: 38.84 ± 7.75% of CD8+ T cells). This evidence concerns the gene CD8A and neoplasm.